Mangalam Drugs and Organics Ltd
₹28.76
(0.24%)
Wed, 03 Jun 2026, 05:14 pm
Health Technology
Pharmaceuticals: Major
24.5KMangalam Drugs and Organics Share Price Live Chart
1 Day
(0.24%)
No Result Found
Summary
Market Cap
45.66
Net Profit
6.72
P/B
0.83
Sector P/E
33.76
P/E
17.46
EV/EBITDA
5.81
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.04
RONW (Industry)
13.17
ROE
4.84
ROCE
8.07
Debt/Equity
0.73
EPS (TTM)
0
Dividend Yield
0
Book Value
60.64
Interest Cover
1.32
Analysis
all
- Mangalam Drugs & Organics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Mangalam Drugs & Organics has been profitable on average in the past, therefore cash runway is not a concern.
- Mangalam Drugs & Organics has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (30.1%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1.7x debt.
- Unable to calculate sustainability of dividends as Mangalam Drugs & Organics has not reported any payouts.
- Unable to evaluate Mangalam Drugs & Organics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Mangalam Drugs & Organics's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Mangalam Drugs & Organics is making a loss, therefore interest payments are not well covered by earnings.
- Mangalam Drugs & Organics's level of debt (65.1%) compared to net worth is high (greater than 40%).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 35.65 | 35.64 | 50.30 | 50.30 | 50.30 |
| FII | 0.32 | 0.13 | 0.11 | 0.53 | 0.47 |
| DII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 64.02 | 64.22 | 49.58 | 49.16 | 49.23 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 36.38 | 32.90 | 30.83 | 29.42 | 27.35 | 25.94 | 22.46 |
| Fibonacci | 32.90 | 31.57 | 30.75 | 29.42 | 28.09 | 27.27 | 25.94 |
| Camarilla | 29.72 | 29.40 | 29.08 | 29.42 | 28.44 | 28.12 | 27.80 |
Pivots Level: Classic
R3
+6.96
36.38
R2
+3.48
32.90
R1
+1.41
30.83
S1
-2.07
27.35
S2
-3.48
25.94
S3
-6.96
22.46
Moving Average
Period
Value
10-EMA
28.98
20-EMA
29.33
30-EMA
29.53
50-EMA
30.15
100-EMA
33.81
200-EMA
44.74
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 14 May 2026 | board-meetings | Accounts | |
| 15 Jan 2026 | board-meetings | Quarterly Results | |
| 20 Nov 2025 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 07 Sept 2025 | agm | ||
| 12 Jul 2025 | egm | ||
| 04 Sept 2024 | agm | ||
| 18 Sept 2023 | agm | ||
| 05 Sept 2022 | agm | ||
| 03 Sept 2021 | agm |
Peer Comparison
Mangalam Drugs and Organics Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Cipla Ltd
Divis Laboratories Ltd
Mangalam Drugs and Organics Ltd About
Mangalam Drugs and Organics engaged in the manufacture and sale of Active Pharmaceutical Ingredients (API) for various therapeutic segments viz. Anti Malaria, Anti-Retrovirat, Anti-Hypertensive etc.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1972
Headquarters
CEO
Govardhan M Dhoot
Employees
Contact
Website
http://www.mangalamdrugs.com
contactus@mangalamdrugs.com
Phone
91-22-22616200/6300/8787
Location
3rd Floor Rupam Building, 239 P D Mello Road, Mumbai, Maharashtra, 400001
Mangalam Drugs and Organics Ltd Company History
| Year | History |
|---|---|
| 2003 |
|
| 2005 |
|
| 2006 |
|
| 2009 |
|
| 2014 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| NEO APEX VENTURE LLP | bulk | Sell | 105753 | 38.01 | 03 Feb 2026 |
| NEO APEX VENTURE LLP | bulk | Sell | 350000 | 37.9 | 03 Feb 2026 |
| NEO APEX VENTURE LLP | bulk | Buy | 455753 | 32.68 | 02 Feb 2026 |
| JYOTIPRASAD TAPARIA | bulk | Sell | 150000 | 42.64 | 13 Jan 2026 |
| SANJAY KUMAR SAINI | bulk | Sell | 95000 | 40.65 | 13 Jan 2026 |
| SHIVKUMAR DAMANI | bulk | Sell | 81999 | 40.61 | 12 Jan 2026 |
| ASHUTOSH TAPARIA | bulk | Sell | 200000 | 40.61 | 12 Jan 2026 |
| SANJAY KUMAR SAINI | bulk | Buy | 95000 | 38.77 | 09 Jan 2026 |
| EPITOME TRADING AND INVESTMENTS | bulk | Sell | 134064 | 38.77 | 09 Jan 2026 |
| EPITOME TRADING AND INVESTMENTS | bulk | Buy | 100000 | 36.84 | 08 Jan 2026 |